An ongoing dialogue on HIV/AIDS, infectious diseases,
April 11th, 2009
Another Drug Linked to PML — Law Firms Waiting for Your Call
The psoriasis drug Raptiva (efalizumab) has been linked to progressive multifocal leukoencephalopathy: On Oct. 16, 2008, FDA updated the FDA-approved labeling for Raptiva to warn of the risk of life-threatening infections, including PML. On Feb. 19, 2009, the FDA issued a Public Health Advisory informing patients and prescribers of the risk of PML in patients taking […]